The FDA rigorously evaluates IBS treatments, but typically only for trials under a year
They have a fantastic team
Recalls & Warnings April 22, 2008 Court Upholds Order for Seasilver Marketers to Pay $120 Million On April 16, 2008, the Federal Trade Commission (FTC) announced that the U.S
has received honoraria from Boehringer Ingelheim, Eli Lilly, Merck, AstraZeneca, Sanofi, Mitsubishi-Tanabe, AbbVie, Janssen, Bayer, Prometic, Bristol Myers Squibb, Maze, Gilead, CSL-Behring, Otsuka, Novartis, Youngene and Novo Nordisk and has received operational funding for clinical trials from Boehringer Ingelheim, Eli Lilly, Merck, Janssen, Sanofi, AstraZeneca, CSL-Behring and Novo Nordisk
With needleless systems, the stress and anxiety often associated with injections can be significantly reduced, potentially improving treatment adherence and health outcomes
(2011) 33:e3612